Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
MEDIFAST INC (MED)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/09/2025: MED (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $15
1 Year Target Price $15
| 0 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -26.04% | Avg. Invested days 17 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/09/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 166.51M USD | Price to earnings Ratio - | 1Y Target Price 15 |
Price to earnings Ratio - | 1Y Target Price 15 | ||
Volume (30-day avg) 1 | Beta 0.89 | 52 Weeks Range 11.57 - 22.66 | Updated Date 07/9/2025 |
52 Weeks Range 11.57 - 22.66 | Updated Date 07/9/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.64 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -1.29% | Operating Margin (TTM) -1.09% |
Management Effectiveness
Return on Assets (TTM) 1.33% | Return on Equity (TTM) -3.32% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 17300339 | Price to Sales(TTM) 0.31 |
Enterprise Value 17300339 | Price to Sales(TTM) 0.31 | ||
Enterprise Value to Revenue 0.03 | Enterprise Value to EBITDA 2.7 | Shares Outstanding 10991000 | Shares Floating 9141623 |
Shares Outstanding 10991000 | Shares Floating 9141623 | ||
Percent Insiders 3.2 | Percent Institutions 76.62 |
Upturn AI SWOT
MEDIFAST INC
Company Overview
History and Background
MEDIFAST INC. was founded in 1980. Initially a medical formula provider, it evolved into a weight management and healthy lifestyle company, focusing on meal replacements and coaching.
Core Business Areas
- OPTAVIA: OPTAVIA is MEDIFAST's primary business segment, offering structured weight-loss programs and products through independent coaches.
Leadership and Structure
MEDIFAST's leadership includes its CEO, Dan Chard, and a board of directors. The company operates with a direct-selling model through its OPTAVIA coaches.
Top Products and Market Share
Key Offerings
- OPTAVIA Program & Fuelings: OPTAVIA offers a structured weight management program that includes meal replacements, known as Fuelings, and support from independent coaches. Market share information is difficult to pinpoint exactly. Competitors are Weight Watchers, Nutrisystem, and Herbalife. Revenue from this segment accounts for the majority of MEDIFAST's revenue.
Market Dynamics
Industry Overview
The weight management industry is competitive, encompassing various approaches from diet plans to surgery. The market is influenced by health trends and consumer preferences.
Positioning
MEDIFAST is positioned in the weight management industry with a focus on meal replacements and coaching. Its competitive advantage lies in the OPTAVIA program and network of coaches.
Total Addressable Market (TAM)
The global weight management market is estimated to be around $250 billion. Medifast has a small percentage of this overall market. They have potential for growth and market penetration.
Upturn SWOT Analysis
Strengths
- Strong brand recognition within its niche
- Network of independent OPTAVIA coaches
- Recurring revenue model through meal replacements
Weaknesses
- Reliance on the direct-selling model, which can be susceptible to regulatory changes
- Customer attrition rate
- Sensitivity to economic downturns
Opportunities
- Expansion into new geographic markets
- Development of new products and services
- Leveraging digital platforms for coach training and customer engagement
Threats
- Increased competition from other weight management programs
- Changes in consumer preferences and dietary trends
- Regulatory scrutiny of direct-selling practices
- Recession
Competitors and Market Share
Key Competitors
- WW
- NUTR
- HLAL
Competitive Landscape
MEDIFAST competes with various weight management programs, focusing on a direct-selling model. Competitors such as WW offer more community meetings, while Nutrisystem focuses on pre-packaged meals.
Growth Trajectory and Initiatives
Historical Growth: MEDIFAST has experienced growth, particularly with the OPTAVIA program, but growth rates fluctuate. Check their reports for previous periods
Future Projections: Future growth is dependent on the execution of strategic initiatives and market conditions. Review reports from financial analysis websites for estimations
Recent Initiatives: MEDIFAST is expanding into new markets and investing in digital platforms. Details are available in press releases.
Summary
MEDIFAST operates in the competitive weight management industry, primarily through its OPTAVIA program and coach network. The company has strengths in its brand and recurring revenue, but faces risks from competition, regulation, and consumer trends. Medifast's future success hinges on expanding its market presence, managing its direct-selling model effectively, and adapting to changing consumer preferences. Despite a recognizable brand, they will need to find more strategic partnerships to better penetrate the market.
Peer Comparison
Sources and Disclaimers
Data Sources:
- MEDIFAST INC's SEC Filings (10-K, 10-Q), Press Releases, Investor Relations Website, Market Research Reports
Disclaimers:
The data provided is for informational purposes only and should not be considered investment advice. Market share data is estimated and may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About MEDIFAST INC
Exchange NYSE | Headquaters Baltimore, MD, United States | ||
IPO Launch date 1993-12-31 | Executive Chairman & CEO Mr. Daniel R. Chard | ||
Sector Consumer Cyclical | Industry Personal Services | Full time employees 504 | Website https://medifastinc.com |
Full time employees 504 | Website https://medifastinc.com | ||
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups, as well as provides coaching support along with community, nutrition, and healthy habits, and helps people in their weight loss journey. It markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.